DOI QR코드

DOI QR Code

Metabolic Syndrome and Insulin Resistance Syndrome among Infertile Women with Polycystic Ovary Syndrome: A Cross-Sectional Study from Central Vietnam

  • Le, Minh Tam (Department of Obstetrics and Gynecology, Hue University of Medicine and Pharmacy, Hue University) ;
  • Nguyen, Vu Quoc Huy (Department of Obstetrics and Gynecology, Hue University of Medicine and Pharmacy, Hue University) ;
  • Truong, Quang Vinh (Department of Obstetrics and Gynecology, Hue University of Medicine and Pharmacy, Hue University) ;
  • Le, Dinh Duong (Department of Public Health, Hue University of Medicine and Pharmacy, Hue University) ;
  • Le, Viet Nguyen Sa (Department of Obstetrics and Gynecology, Hue Central Hospital) ;
  • Cao, Ngoc Thanh (Department of Obstetrics and Gynecology, Hue University of Medicine and Pharmacy, Hue University)
  • 투고 : 2018.08.01
  • 심사 : 2018.08.23
  • 발행 : 2018.12.31

초록

Background: Polycystic ovarian syndrome (PCOS) is one of the most common endocrinopathies among reproductive-age women. Its metabolic features often overlap with those associated with metabolic syndrome (MS) and insulin resistance syndrome (IRS). The objective of this study was to determine the prevalence and predictors of MS and IRS in infertile Vietnamese women with PCOS. Methods: A cross-sectional study was conducted at a tertiary fertility centre at Hue University Hospital from June 2016 to November 2017. A total of 441 infertile women diagnosed with PCOS based on the revised 2003 Rotterdam consensus criteria were enrolled. MS and IRS were defined based on the National Heart, Lung, and Blood Institute/American Heart Association Adult Treatment Panel III 2005 and American College of Endocrinology IRS 2003 criteria, respectively. Complete clinical and biochemical measurements of 318 women were available for analysis. Independent predictors of MS and IRS were identified using multivariate logistic regression. Results: The overall prevalence of MS and IRS in women with PCOS was 10.4% and 27.0%, respectively. We identified older age (>30 years) and obesity as independent predictors of MS and IRS. Elevated anti-$M{\ddot{u}}llerian$ hormone levels increased the risk of IRS, but not that of MS. Conclusion: MS and IRS are prevalent disorders among infertile Vietnamese women with PCOS. PCOS is not solely a reproductive problem. Screening and early intervention for MS and/or IRS based on anthropometric, metabolic, and reproductive hormone risk factors should be an integral part of fertility care.

키워드

참고문헌

  1. Bozdag G, Mumusoglu S, Zengin D, Karabulut E, Yildiz BO. The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod 2016;31:2841-55. https://doi.org/10.1093/humrep/dew218
  2. Teede H, Deeks A, Moran L. Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC Med 2010;8:41. https://doi.org/10.1186/1741-7015-8-41
  3. Ehrmann DA, Barnes RB, Rosenfield RL, Cavaghan MK, Imperial J. Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care 1999;22:141-6. https://doi.org/10.2337/diacare.22.1.141
  4. Rocha MP, Marcondes JA, Barcellos CR, Hayashida SA, Curi DD, da Fonseca AM, et al. Dyslipidemia in women with polycystic ovary syndrome: incidence, pattern and predictors. Gynecol Endocrinol 2011;27:814-9. https://doi.org/10.3109/09513590.2010.508852
  5. Legro RS. Obesity and PCOS: implications for diagnosis and treatment. Semin Reprod Med 2012;30:496-506. https://doi.org/10.1055/s-0032-1328878
  6. Stepto NK, Cassar S, Joham AE, Hutchison SK, Harrison CL, Goldstein RF, et al. Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic-hyperinsulaemic clamp. Hum Reprod 2013;28:777-84. https://doi.org/10.1093/humrep/des463
  7. Einhorn D, Reaven GM, Cobin RH, Ford E, Ganda OP, Handelsman Y, et al. American College of Endocrinology position statement on the insulin resistance syndrome. Endocr Pract 2003;9:237-52.
  8. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005;112:2735-52. https://doi.org/10.1161/CIRCULATIONAHA.105.169404
  9. Balkau B, Charles MA, Drivsholm T, Borch-Johnsen K, Wareham N, Yudkin JS, et al. Frequency of the WHO metabolic syndrome in European cohorts, and an alternative definition of an insulin resistance syndrome. Diabetes Metab 2002;28:364-76.
  10. Li R, Yu G, Yang D, Li S, Lu S, Wu X, et al. Prevalence and predictors of metabolic abnormalities in Chinese women with PCOS: a cross- sectional study. BMC Endocr Disord 2014;14:76. https://doi.org/10.1186/1472-6823-14-76
  11. Yildiz BO, Bozdag G, Yapici Z, Esinler I, Yarali H. Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria. Hum Reprod 2012;27:3067-73. https://doi.org/10.1093/humrep/des232
  12. Rossi B, Sukalich S, Droz J, Griffin A, Cook S, Blumkin A, et al. Prevalence of metabolic syndrome and related characteristics in obese adolescents with and without polycystic ovary syndrome. J Clin Endocrinol Metab 2008;93:4780-6. https://doi.org/10.1210/jc.2008-1198
  13. Mandrelle K, Kamath MS, Bondu DJ, Chandy A, Aleyamma T, George K. Prevalence of metabolic syndrome in women with polycystic ovary syndrome attending an infertility clinic in a tertiary care hospital in south India. J Hum Reprod Sci 2012;5:26-31. https://doi.org/10.4103/0974-1208.97791
  14. Cheung LP, Ma RC, Lam PM, Lok IH, Haines CJ, So WY, et al. Cardiovascular risks and metabolic syndrome in Hong Kong Chinese women with polycystic ovary syndrome. Hum Reprod 2008;23:1431-8. https://doi.org/10.1093/humrep/den090
  15. Indhavivadhana S, Wongwananuruk T, Rattanachaiyanont M, Techatraisak K, Leerasiri P, Tanmahasamut P, et al. Prevalence of metabolic syndrome in reproductive-aged polycystic ovary syndrome Thai women. J Med Assoc Thai 2010;93:653-60.
  16. Reyes-Munoz E, Ortega-Gonzalez C, Martinez-Cruz N, Arce-Sanchez L, Estrada-Gutierrez G, Moran C, et al. Association of obesity and overweight with the prevalence of insulin resistance, pre-diabetes and clinical-biochemical characteristics among infertile Mexican women with polycystic ovary syndrome: a cross-sectional study. BMJ Open 2016;6:e012107. https://doi.org/10.1136/bmjopen-2016-012107
  17. Chen X, Yang D, Li L, Feng S, Wang L. Abnormal glucose tolerance in Chinese women with polycystic ovary syndrome. Hum Reprod 2006;21:2027-32. https://doi.org/10.1093/humrep/del142
  18. Sharma S, Majumdar A. Prevalence of metabolic syndrome in relation to body mass index and polycystic ovarian syndrome in Indian women. J Hum Reprod Sci 2015;8:202-8. https://doi.org/10.4103/0974-1208.170394
  19. Dabadghao P, Roberts BJ, Wang J, Davies MJ, Norman RJ. Glucose tolerance abnormalities in Australian women with polycystic ovary syndrome. Med J Aust 2007;187:328-31. https://doi.org/10.5694/j.1326-5377.2007.tb01273.x
  20. Gambineri A, Pelusi C, Manicardi E, Vicennati V, Cacciari M, Morselli-Labate AM, et al. Glucose intolerance in a large cohort of Mediterranean women with polycystic ovary syndrome: phenotype and associated factors. Diabetes 2004;53:2353-8. https://doi.org/10.2337/diabetes.53.9.2353
  21. Wongwananuruk T, Rattanachaiyanont M, Indhavivadhana S, Leerasiri P, Techatraisak K, Tanmahasamut P, et al. Prevalence and clinical predictors of insulin resistance in reproductive-aged thai women with polycystic ovary syndrome. Int J Endocrinol 2012;2012:529184.
  22. Pantasri T, Vutyavanich T, Sreshthaputra O, Srisupundit K, Piromlertamorn W. Metabolic syndrome and insulin resistance in Thai women with polycystic ovary syndrome. J Med Assoc Thai 2010;93:406-12.
  23. Vazquez G, Duval S, Jacobs DR Jr, Silventoinen K. Comparison of body mass index, waist circumference, and waist/hip ratio in predicting incident diabetes: a meta-analysis. Epidemiol Rev 2007;29:115-28. https://doi.org/10.1093/epirev/mxm008
  24. Meigs JB, Wilson PW, Nathan DM, D'Agostino RB Sr, Williams K, Haffner SM. Prevalence and characteristics of the metabolic syndrome in the San Antonio Heart and Framingham Offspring Studies. Diabetes 2003;52:2160-7. https://doi.org/10.2337/diabetes.52.8.2160
  25. Pellatt L, Hanna L, Brincat M, Galea R, Brain H, Whitehead S, et al. Granulosa cell production of anti-Mullerian hormone is increased in polycystic ovaries. J Clin Endocrinol Metab 2007;92:240-5. https://doi.org/10.1210/jc.2006-1582
  26. Feldman RA, O'Neill K, Butts SF, Dokras A. Antimullerian hormone levels and cardiometabolic risk in young women with polycystic ovary syndrome. Fertil Steril 2017;107:276-81. https://doi.org/10.1016/j.fertnstert.2016.10.009
  27. Skalba P, Cygal A, Madej P, Dabkowska-Huc A, Sikora J, Martirosian G, et al. Is the plasma anti-Mullerian hormone (AMH) level associated with body weight and metabolic, and hormonal disturbances in women with and without polycystic ovary syndrome? Eur J Obstet Gynecol Reprod Biol 2011;158:254-9. https://doi.org/10.1016/j.ejogrb.2011.06.006
  28. Cui Y, Shi Y, Cui L, Han T, Gao X, Chen ZJ. Age-specific serum antimullerian hormone levels in women with and without polycystic ovary syndrome. Fertil Steril 2014;102:230-6. https://doi.org/10.1016/j.fertnstert.2014.03.032
  29. Cassar S, Teede HJ, Moran LJ, Joham AE, Harrison CL, Strauss BJ, et al. Polycystic ovary syndrome and anti-Mullerian hormone: role of insulin resistance, androgens, obesity and gonadotrophins. Clin Endocrinol (Oxf) 2014;81:899-906. https://doi.org/10.1111/cen.12557
  30. Hong TK, Trang NH, Dibley MJ. Prevalence of metabolic syndrome and factor analysis of cardiovascular risk clustering among adolescents in Ho Chi Minh City, Vietnam. Prev Med 2012;55:409-11. https://doi.org/10.1016/j.ypmed.2012.09.002
  31. Binh TQ, Phuong PT, Nhung BT, Tung do D. Metabolic syndrome among a middle-aged population in the Red River Delta region of Vietnam. BMC Endocr Disord 2014;14:77. https://doi.org/10.1186/1472-6823-14-77
  32. Dao HH, Do QT, Sakamoto J. Increased frequency of metabolic syndrome among Vietnamese women with early rheumatoid arthritis: a cross-sectional study. Arthritis Res Ther 2010;12:R218. https://doi.org/10.1186/ar3203
  33. Cheal KL, Abbasi F, Lamendola C, McLaughlin T, Reaven GM, Ford ES. Relationship to insulin resistance of the Adult Treatment Panel III diagnostic criteria for identification of the metabolic syndrome. Diabetes 2004;53:1195-200. https://doi.org/10.2337/diabetes.53.5.1195
  34. Dunaif A, Segal KR, Futterweit W, Dobrjansky A. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes 1989;38:1165-74. https://doi.org/10.2337/diab.38.9.1165
  35. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care 2004;27 Suppl 1:S15-35. https://doi.org/10.2337/diacare.27.2007.S15